The US Food and Drug Administration (FDA) has approved a product known as enzalutamide (Xtandi®) to be used in a new way. The body, after an in-depth review says that it is ideal for handling a condition called prostate cancer (mHSPC). A close outlook Sometime back, the company gave its approval to the product for […]
FDA
Recent Posts
Frontera In Discussions with STX Border Finance Partners in Connection With Pending Acquisition of Texas Money Exchange
TNRG Signs Reg A Offering Agreement
Ultrack Provides Q1 Update on The Company’s Flagship ELD Certification
Advisory Excellence Appoints Grace El Mahmoud Marabe and LMG Consultants in the United Arab Emirates
Advisory Excellence Appoints Ayobami Tunde and Tunde & Adisa Legal Practitioners in Nigeria
Popular Post
-
UCASU to Acquire 10,000 Sqft Cannabis Property and Build 5,000 Sqft More
-
UC Asset’s new $3M cannabis property acquisition includes protection for existing shareholders
-
ZICIX+CTIP-FII SIGNS CONTRACT WITH IFCI TO DEVELOP $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEY
-
Kimberly Goldwin Poised to Become Next President of ABC News
-
JPMorgan Bringing Back Employees to Work From Office
